Rybelsus is the first and only oral GLP-1 medication, offering the proven effectiveness of semaglutide in a convenient once-daily tablet. Perfect for patients who prefer not to inject, Rybelsus delivers similar appetite suppression and weight loss results as injectable semaglutide, helping you lose 8-12% of your body weight while improving metabolic health.
